{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:21:18Z","timestamp":1777317678562,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1842,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1439-0507.2009.01733.x","type":"journal-article","created":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T08:36:08Z","timestamp":1244104568000},"page":"438-442","source":"Crossref","is-referenced-by-count":6,"title":["Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis"],"prefix":"10.1111","volume":"53","author":[{"given":"Zekaver","family":"Odabasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor L.","family":"Paetznick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose R.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Rex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard J.","family":"Leitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"issue":"Suppl. 3B","key":"10.1111\/j.1439-0507.2009.01733.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF01963467","article-title":"Emerging fungal pathogens","volume":"8","author":"Anaissie","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/JCM.20.6.1194-1195.1984","article-title":"Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance","volume":"20","author":"Merz","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/AAC.22.3.482","article-title":"Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States","volume":"22","author":"Stiller","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(83)90511-9","article-title":"Long term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients","volume":"74","author":"Horsburgh","year":"1983","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JCM.30.12.3138-3145.1992","article-title":"Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests","volume":"30","author":"Espinel-Ingroff","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/AAC.37.1.39","article-title":"Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts","volume":"37","author":"Fromtling","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/JCM.26.8.1437-1441.1988","article-title":"Multicenter evaluation of four methods of yeast inoculum preparation","volume":"26","author":"Pfaller","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.34.9.1648","article-title":"Collaborative investigation of variables in susceptibility testing of yeasts","volume":"34","author":"Pfaller","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.29.6.1089-1094.1991","article-title":"Comparison study of broth macrodilution and microdilution antifungal susceptibility tests","volume":"29","author":"Espinel-Ingroff","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/JCM.26.11.2307-2312.1988","article-title":"Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing","volume":"26","author":"Guinet","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1128\/JCM.30.8.1976-1981.1992","article-title":"Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans","volume":"30","author":"Shawar","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB14|cit14","first-page":"306","article-title":"Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B","volume":"30","author":"Polak","year":"1987","journal-title":"Mykosen"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB15|cit15","first-page":"1805","volume-title":"Antimicrob Agents Chemother","volume":"36","author":"Pfaller","year":"1992"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB16|cit16","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.6.4.367","article-title":"Antifungal susceptibility testing","volume":"6","author":"Rex","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","article-title":"Resistance of Candida species to fluconazole","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.42.1.129","article-title":"Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis","volume":"42","author":"Rex","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/JCM.36.1.153-156.1998","article-title":"Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method","volume":"36","author":"Revankar","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing endpoint phenotype in antifungal susceptibility testing is pH-dependent","volume":"43","author":"Marr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB22|cit22","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"National Committee for Clinical Laboratory Standards","year":"2008"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.0933-7407.2000.00603.x","article-title":"Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- vs. 48-h incubation and 50 versus 80% reduction in growth","volume":"44","author":"St-Germain","year":"2001","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2009.01733.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","article-title":"Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in\u2003vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2009.01733.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1439-0507.2009.01733.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T03:57:01Z","timestamp":1625630221000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2009.01733.x"}},"subtitle":["24- and 48-h itraconazole MICs"],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2009.01733.x","relation":{},"ISSN":["0933-7407"],"issn-type":[{"value":"0933-7407","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}